"10.1371_journal.pone.0083643","plos one","2013-12-31T00:00:00Z","André R S Périssé; Laura Smeaton; Yun Chen; Alberto La Rosa; Ann Walawander; Apsara Nair; Beatriz Grinsztejn; Breno Santos; Cecilia Kanyama; James Hakim; Mulinda Nyirenda; Nagalingeswaran Kumarasamy; Umesh G Lalloo; Timothy Flanigan; Thomas B Campbell; Michael D Hughes; on behalf of the P E A R L S study team of the ACTG","Departamento de Ciências Biológicas, Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil; Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts, United States of America; Asociacion Civil Impacta Salud y Educacion - Barranco, Lima, Peru; Frontier Science and Technology Research Foundation, Amherst, New York, United States of America; Evandro Chagas Clinical Research Institute, Fiocruz, Rio de Janeiro, Brazil; Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil; Kamuzu Central Hospital, Lilongwe, Malawi; University of Zimbabwe College of Health Sciences, Harare, Zimbabwe; Mulinda Nyirenda, College of Medicine, University of Malawi, Blantyre, Malawi; YRG Centre for AIDS Research and Education, Chennai, India; Nelson R. Mandela School of Medicine, Durban, South Africa; Brown Medical School, Providence, Rhode Island, United States of America; Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, United States of America; Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America","Conceived and designed the experiments: TBC TF NK JH. Performed the experiments: ALR AW AN BG BS CK MN NK UGL TF TBC. Analyzed the data: ARSP LS YC MDH. Wrote the paper: ARSP BG TBC MDH.","Thomas Campbell declares previously receiving payment for being an advisory board member for Gliead Sciences. Laura Smeaton declare being a paid data monitoring member for Pfizer. Michael Hughes declares previously being a paid data monitoring committee member for Boehringer Ingelheim, Medicines Development, Pfizer and Tibotec. All other authors have no potential conflicts of interest to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","12","André R S Périssé","ARSP",17,TRUE,4,11,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
